Cargando…

21-Benzylidene Digoxin: A Proapoptotic Cardenolide of Cancer Cells That Up-Regulates Na,K-ATPase and Epithelial Tight Junctions

Cardiotonic steroids are used to treat heart failure and arrhythmia and have promising anticancer effects. The prototypic cardiotonic steroid ouabain may also be a hormone that modulates epithelial cell adhesion. Cardiotonic steroids consist of a steroid nucleus and a lactone ring, and their biologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha, Sayonarah C., Pessoa, Marco T. C., Neves, Luiza D. R., Alves, Silmara L. G., Silva, Luciana M., Santos, Herica L., Oliveira, Soraya M. F., Taranto, Alex G., Comar, Moacyr, Gomes, Isabella V., Santos, Fabio V., Paixão, Natasha, Quintas, Luis E. M., Noël, François, Pereira, Antonio F., Tessis, Ana C. S. C., Gomes, Natalia L. S., Moreira, Otacilio C., Rincon-Heredia, Ruth, Varotti, Fernando P., Blanco, Gustavo, Villar, Jose A. F. P., Contreras, Rubén G., Barbosa, Leandro A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188576/
https://www.ncbi.nlm.nih.gov/pubmed/25290152
http://dx.doi.org/10.1371/journal.pone.0108776
_version_ 1782338248469643264
author Rocha, Sayonarah C.
Pessoa, Marco T. C.
Neves, Luiza D. R.
Alves, Silmara L. G.
Silva, Luciana M.
Santos, Herica L.
Oliveira, Soraya M. F.
Taranto, Alex G.
Comar, Moacyr
Gomes, Isabella V.
Santos, Fabio V.
Paixão, Natasha
Quintas, Luis E. M.
Noël, François
Pereira, Antonio F.
Tessis, Ana C. S. C.
Gomes, Natalia L. S.
Moreira, Otacilio C.
Rincon-Heredia, Ruth
Varotti, Fernando P.
Blanco, Gustavo
Villar, Jose A. F. P.
Contreras, Rubén G.
Barbosa, Leandro A.
author_facet Rocha, Sayonarah C.
Pessoa, Marco T. C.
Neves, Luiza D. R.
Alves, Silmara L. G.
Silva, Luciana M.
Santos, Herica L.
Oliveira, Soraya M. F.
Taranto, Alex G.
Comar, Moacyr
Gomes, Isabella V.
Santos, Fabio V.
Paixão, Natasha
Quintas, Luis E. M.
Noël, François
Pereira, Antonio F.
Tessis, Ana C. S. C.
Gomes, Natalia L. S.
Moreira, Otacilio C.
Rincon-Heredia, Ruth
Varotti, Fernando P.
Blanco, Gustavo
Villar, Jose A. F. P.
Contreras, Rubén G.
Barbosa, Leandro A.
author_sort Rocha, Sayonarah C.
collection PubMed
description Cardiotonic steroids are used to treat heart failure and arrhythmia and have promising anticancer effects. The prototypic cardiotonic steroid ouabain may also be a hormone that modulates epithelial cell adhesion. Cardiotonic steroids consist of a steroid nucleus and a lactone ring, and their biological effects depend on the binding to their receptor, Na,K-ATPase, through which, they inhibit Na(+) and K(+) ion transport and activate of several intracellular signaling pathways. In this study, we added a styrene group to the lactone ring of the cardiotonic steroid digoxin, to obtain 21-benzylidene digoxin (21-BD), and investigated the effects of this synthetic cardiotonic steroid in different cell models. Molecular modeling indicates that 21-BD binds to its target Na,K-ATPase with low affinity, adopting a different pharmacophoric conformation when bound to its receptor than digoxin. Accordingly, 21-DB, at relatively high µM amounts inhibits the activity of Na,K-ATPase α(1), but not α(2) and α(3) isoforms. In addition, 21-BD targets other proteins outside the Na,K-ATPase, inhibiting the multidrug exporter Pdr5p. When used on whole cells at low µM concentrations, 21-BD produces several effects, including: 1) up-regulation of Na,K-ATPase expression and activity in HeLa and RKO cancer cells, which is not found for digoxin, 2) cell specific changes in cell viability, reducing it in HeLa and RKO cancer cells, but increasing it in normal epithelial MDCK cells, which is different from the response to digoxin, and 3) changes in cell-cell interaction, altering the molecular composition of tight junctions and elevating transepithelial electrical resistance of MDCK monolayers, an effect previously found for ouabain. These results indicate that modification of the lactone ring of digoxin provides new properties to the compound, and shows that the structural change introduced could be used for the design of cardiotonic steroid with novel functions.
format Online
Article
Text
id pubmed-4188576
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41885762014-10-10 21-Benzylidene Digoxin: A Proapoptotic Cardenolide of Cancer Cells That Up-Regulates Na,K-ATPase and Epithelial Tight Junctions Rocha, Sayonarah C. Pessoa, Marco T. C. Neves, Luiza D. R. Alves, Silmara L. G. Silva, Luciana M. Santos, Herica L. Oliveira, Soraya M. F. Taranto, Alex G. Comar, Moacyr Gomes, Isabella V. Santos, Fabio V. Paixão, Natasha Quintas, Luis E. M. Noël, François Pereira, Antonio F. Tessis, Ana C. S. C. Gomes, Natalia L. S. Moreira, Otacilio C. Rincon-Heredia, Ruth Varotti, Fernando P. Blanco, Gustavo Villar, Jose A. F. P. Contreras, Rubén G. Barbosa, Leandro A. PLoS One Research Article Cardiotonic steroids are used to treat heart failure and arrhythmia and have promising anticancer effects. The prototypic cardiotonic steroid ouabain may also be a hormone that modulates epithelial cell adhesion. Cardiotonic steroids consist of a steroid nucleus and a lactone ring, and their biological effects depend on the binding to their receptor, Na,K-ATPase, through which, they inhibit Na(+) and K(+) ion transport and activate of several intracellular signaling pathways. In this study, we added a styrene group to the lactone ring of the cardiotonic steroid digoxin, to obtain 21-benzylidene digoxin (21-BD), and investigated the effects of this synthetic cardiotonic steroid in different cell models. Molecular modeling indicates that 21-BD binds to its target Na,K-ATPase with low affinity, adopting a different pharmacophoric conformation when bound to its receptor than digoxin. Accordingly, 21-DB, at relatively high µM amounts inhibits the activity of Na,K-ATPase α(1), but not α(2) and α(3) isoforms. In addition, 21-BD targets other proteins outside the Na,K-ATPase, inhibiting the multidrug exporter Pdr5p. When used on whole cells at low µM concentrations, 21-BD produces several effects, including: 1) up-regulation of Na,K-ATPase expression and activity in HeLa and RKO cancer cells, which is not found for digoxin, 2) cell specific changes in cell viability, reducing it in HeLa and RKO cancer cells, but increasing it in normal epithelial MDCK cells, which is different from the response to digoxin, and 3) changes in cell-cell interaction, altering the molecular composition of tight junctions and elevating transepithelial electrical resistance of MDCK monolayers, an effect previously found for ouabain. These results indicate that modification of the lactone ring of digoxin provides new properties to the compound, and shows that the structural change introduced could be used for the design of cardiotonic steroid with novel functions. Public Library of Science 2014-10-07 /pmc/articles/PMC4188576/ /pubmed/25290152 http://dx.doi.org/10.1371/journal.pone.0108776 Text en © 2014 Rocha et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Rocha, Sayonarah C.
Pessoa, Marco T. C.
Neves, Luiza D. R.
Alves, Silmara L. G.
Silva, Luciana M.
Santos, Herica L.
Oliveira, Soraya M. F.
Taranto, Alex G.
Comar, Moacyr
Gomes, Isabella V.
Santos, Fabio V.
Paixão, Natasha
Quintas, Luis E. M.
Noël, François
Pereira, Antonio F.
Tessis, Ana C. S. C.
Gomes, Natalia L. S.
Moreira, Otacilio C.
Rincon-Heredia, Ruth
Varotti, Fernando P.
Blanco, Gustavo
Villar, Jose A. F. P.
Contreras, Rubén G.
Barbosa, Leandro A.
21-Benzylidene Digoxin: A Proapoptotic Cardenolide of Cancer Cells That Up-Regulates Na,K-ATPase and Epithelial Tight Junctions
title 21-Benzylidene Digoxin: A Proapoptotic Cardenolide of Cancer Cells That Up-Regulates Na,K-ATPase and Epithelial Tight Junctions
title_full 21-Benzylidene Digoxin: A Proapoptotic Cardenolide of Cancer Cells That Up-Regulates Na,K-ATPase and Epithelial Tight Junctions
title_fullStr 21-Benzylidene Digoxin: A Proapoptotic Cardenolide of Cancer Cells That Up-Regulates Na,K-ATPase and Epithelial Tight Junctions
title_full_unstemmed 21-Benzylidene Digoxin: A Proapoptotic Cardenolide of Cancer Cells That Up-Regulates Na,K-ATPase and Epithelial Tight Junctions
title_short 21-Benzylidene Digoxin: A Proapoptotic Cardenolide of Cancer Cells That Up-Regulates Na,K-ATPase and Epithelial Tight Junctions
title_sort 21-benzylidene digoxin: a proapoptotic cardenolide of cancer cells that up-regulates na,k-atpase and epithelial tight junctions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188576/
https://www.ncbi.nlm.nih.gov/pubmed/25290152
http://dx.doi.org/10.1371/journal.pone.0108776
work_keys_str_mv AT rochasayonarahc 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT pessoamarcotc 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT nevesluizadr 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT alvessilmaralg 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT silvalucianam 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT santosherical 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT oliveirasorayamf 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT tarantoalexg 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT comarmoacyr 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT gomesisabellav 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT santosfabiov 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT paixaonatasha 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT quintasluisem 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT noelfrancois 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT pereiraantoniof 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT tessisanacsc 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT gomesnatalials 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT moreiraotacilioc 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT rinconherediaruth 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT varottifernandop 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT blancogustavo 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT villarjoseafp 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT contrerasrubeng 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions
AT barbosaleandroa 21benzylidenedigoxinaproapoptoticcardenolideofcancercellsthatupregulatesnakatpaseandepithelialtightjunctions